Article
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
Clinical lung cancer - 1 Nov 2014
He Yan-yan, Zhang Xu-chao, Yang Jin-ji, Niu Fei-yu, Zeng Zhu, Yan Hong-hong, Xu Chong-rui, Guan Ji-lin, Zhong Wen-zhao, Yang Lu-lu, Guo Long-hua, Wu Yi-long
Abstract excerpt
BACKGROUND: TNM stage remains the most important prognostic factor in clinical practice. The 7th edition lung cancer staging system has not considered some important prognostic factors, such as the number of metastatic organ sites and the molecular biologic characterization. PATIENTS AND METHODS: Using driver gene alternation and tumor burden, advanced NSCLC cases were divided into 3 groups: M1-I group, epidermal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
